Nanovaccine: A Hope to Triumph the Battle Against Novel Coronavirus Disease 2019 (COVID-19).

导出 LinkOut

翻译打印收藏纠错

作者： Anurag Kumar,Singh ^[1] ; Anand,Maurya ^[2] ; Gaurav,Mishra ^[2] ; Rajendra,Awasthi ^[3] ; Kamal,Dua ^[4] ; Giriraj T,Kulkarni ^[5]

作者单位： Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India. ^[1] Department of Medicinal Chemistry, Institute of Medical Sciences, Faculty of Ayurveda, Banaras Hindu University, Varanasi, Uttar Pradesh, India. ^[2] Department of Pharmaceutical Sciences, School of Health Sciences & Technology, University of Petroleum and Energy Studies (UPES), Energy Acres, Bidholi, Via-Prem Nagar, Dehradun - 248 007, Uttarakhand, India. ^[3] Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo NSW 2007, Australia. ^[4] Gokaraju Rangaraju College of Pharmacy, Hyderabad 500090, Telangana, India. ^[5]

关键词 COVID-19 Coronavirus SARS-CoV-2 liposome nanovaccine viral outbreak

主题词人类(Humans);专利(主题)(Patents as Topic);疫苗, 合成(Vaccines, Synthetic)

DOI 10.2174/1872210515666210720130736

PMID 34303337

发布时间 2023-02-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交